Purchase Order 75N92B20P00056

Otogenetics Corporation, a minority-owned, small disadvantaged business, has been awarded a $24,849 firm-fixed-price purchase order contract by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases. The contract, which is not set aside for any specific business category, is for the provision of next-generation sequencing laboratory services, including whole exome sequencing, clinical genetic testing, and data analysis, to support research...

This firm fixed-price purchase order in the amount of $72,600.00 was awarded by the National Institute of Child Health and Human Development (NICHD) to Novogene Corporation Inc., a minority-owned small business, for whole exome sequencing services. The award is for an ongoing project focused on identifying new genetic causes of adrenal and pituitary tumors and analyzing the effects of such genetic alterations. The effort involves DNA library preparation, sequencing, and customized bioinformatics...

Novogene Corp Inc., a minority-owned small business, has been awarded a $13,982 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide RNA sequencing services in Bethesda, Maryland. The sequencing will support the agency's biomedical research efforts. As a prime contractor supporting multiple federal agencies, Novogene has over 100 contracts to conduct genomic sequencing and analysis for studies into diseases,...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $345,333 firm fixed price purchase order to Genewiz, LLC for whole genome sequencing services using 90 human induced pluripotent stem cell samples. The solicitation sought these sequencing services to be performed within 45 days of sample receipt in September 2020. Genewiz will conduct the work at its facility in South Plainfield, New Jersey as the incumbent...

This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) to Otogenetics Corporation, a minority-owned, small disadvantaged, woman-owned business. The $15,999 firm fixed-price purchase order was for next-generation sequencing laboratory services, including whole exome sequencing, clinical genetic testing, and data analysis to support NIH research programs. Otogenetics has been awarded multiple federal...

The National Heart, Lung and Blood Institute (NHLBI) has awarded a delivery order valued at $7.0M to New York Genome Center, Inc. (NYGC) for RNA sequencing services under the Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE) program. The task order, awarded on September 23, 2024, is scheduled for completion by September 22, 2026, and will be performed at NYGC's facility in New York, NY. This delivery order was issued without a set-aside designation and operates...

This is a federal contract award to Seqgen, Inc., a Torrance, California-based provider of scientific instruments and lab equipment, including genetic analyzers and sequencers. The contract, valued at $86,300.00, was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the National Institutes of Health (NIH). The contract is for the provision of genomic sequencing systems and services, and does not have a set-aside designation....

Genedx, LLC, a division of Opko Health, Inc., has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide exome and genome sequencing with optional mitochondrial testing for various patients. The contract has a period of performance of just over one year, running from September 2023 through August 2024. Genedx will perform the sequencing and testing services at its laboratory location in Montgomery Village,...

This firm-fixed price purchase order for $600,000 was awarded by the National Institute on Aging, a component of the National Institutes of Health within the Department of Health and Human Services, to Psomagen, Inc. for whole genome sequencing services. Under the terms of the contract, Psomagen will sequence 1,000 human samples to 30x coverage using Illumina sequencing technologies and deliver raw sequencing data files within 4-6 weeks. The work will be performed in Potomac, Maryland over a one...

This firm fixed-price purchase order was awarded by the Office of the Chief Operating Officer (a civilian agency), a component of the National Institutes of Health (NIH), to Genedx, LLC, a for-profit limited liability company. The $81,666 contract is for medical laboratory testing services, specifically genetic testing and diagnostic services. Genedx, a wholly owned subsidiary of Opko Health, Inc., provides comprehensive genetic testing, including mutation analysis, exome and genome...